相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Neurotrophic and neuroprotective effects of a monomeric GLP-1/GIP/Gcg receptor triagonist in cellular and rodent models of mild traumatic brain injury
Yazhou Li et al.
EXPERIMENTAL NEUROLOGY (2020)
Neuroprotective Effects and Treatment Potential of Incretin Mimetics in a Murine Model of Mild Traumatic Brain Injury
Miaad Bader et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Glucagon-like peptide-1 (GLP-1)-based receptor agonists as a treatment for Parkinson's disease
Elliot J. Glotfelty et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2020)
Brain insulin resistance: role in neurodegenerative disease and potential for targeting
Christian Holscher
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2020)
PT320, Sustained-Release Exendin-4, Mitigates L-DOPA-Induced Dyskinesia in a Rat 6-Hydroxydopamine Model of Parkinson's Disease
Seong-Jin Yu et al.
FRONTIERS IN NEUROSCIENCE (2020)
Diabetes medications and risk of Parkinson's disease: a cohort study of patients with diabetes
Ruth Brauer et al.
BRAIN (2020)
Role of Insulin in Neurotrauma and Neurodegeneration: A Review
Michael Shaughness et al.
FRONTIERS IN NEUROSCIENCE (2020)
Glucagon-like peptide-1 cleavage product GLP-1(9-36) reduces neuroinflammation from stroke via the activation of insulin-like growth factor 1 receptor in astrocytes
Jing Huang et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2020)
Physiology and Pharmacology of DPP-4 in Glucose Homeostasis and the Treatment of Type 2 Diabetes
Carolyn F. Deacon
FRONTIERS IN ENDOCRINOLOGY (2019)
Pharmacokinetics and efficacy of PT302, a sustained-release Exenatide formulation, in a murine model of mild traumatic brain injury
Miaad Bader et al.
NEUROBIOLOGY OF DISEASE (2019)
Necrosis, apoptosis, necroptosis, three modes of action of dopaminergic neuron neurotoxins
Noelle Callizot et al.
PLOS ONE (2019)
A Pilot Study of Exenatide Actions in Alzheimer's Disease
Roger J. Mullins et al.
CURRENT ALZHEIMER RESEARCH (2019)
Liraglutide improves vascular dysfunction by regulating a cAMP-independent PKA-AMPK pathway in perivascular adipose tissue in obese mice
Fang Han et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Protection against stroke with glucagon-like peptide 1 receptor agonists: a systematic review and meta-analysis
F. Barkas et al.
EUROPEAN JOURNAL OF NEUROLOGY (2019)
Incretin Mimetics as Rational Candidates for the Treatment of Traumatic Brain Injury
Elliot J. Glotfelty et al.
ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2019)
Neuroprotective effects of a triple GLP-1/GIP/glucagon receptor agonist in the APP/PS1 transgenic mouse model of Alzheimer's disease
Jingjing Tai et al.
BRAIN RESEARCH (2018)
A novel GLP-1/GIP/Gcg triagonist reduces cognitive deficits and pathology in the 3xTg mouse model of Alzheimer's disease
Tian Li et al.
HIPPOCAMPUS (2018)
Pleiotropic Effects of GLP-1 and Analogs on Cell Signaling, Metabolism, and Function
Jordan Rowlands et al.
FRONTIERS IN ENDOCRINOLOGY (2018)
Neurotrophic and neuroprotective effects of oxyntomodulin in neuronal cells and a rat model of stroke
Yazhou Li et al.
EXPERIMENTAL NEUROLOGY (2017)
Glucagon-like peptide-1 cleavage product GLP-1 (9-36) amide enhances hippocampal long-term synaptic plasticity in correlation with suppression of Kv4.2 expression and eEF2 phosphorylation
Stephen M. Day et al.
HIPPOCAMPUS (2017)
Neurotoxic reactive astrocytes are induced by activated microglia
Shane A. Liddelow et al.
NATURE (2017)
Oxidative Stress and the Central Nervous System
Samina Salim
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2017)
A New Treatment Strategy for Parkinson's Disease through the Gut-Brain Axis: The Glucagon-Like Peptide-1 Receptor Pathway
Dong Seok Kim et al.
CELL TRANSPLANTATION (2017)
Exenatide exerts direct protective effects on endothelial cells through the AMPK/Akt/eNOS pathway in a GLP-1 receptor-dependent manner
Rui Wei et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2016)
The glucagon-like peptide 1 (GLP) receptor as a therapeutic target in Parkinson's disease: mechanisms of action
Dilan Athauda et al.
DRUG DISCOVERY TODAY (2016)
Reduced incidence of Parkinson's disease after dipeptidyl peptidase-4 inhibitorsA nationwide case-control study
Per Svenningsson et al.
MOVEMENT DISORDERS (2016)
In Alzheimer's Disease, 6-Month Treatment with GLP-1 Analog Prevents Decline of Brain Glucose Metabolism: Randomized, Placebo-Controlled, Double-Blind Clinical Trial
Michael Gejl et al.
FRONTIERS IN AGING NEUROSCIENCE (2016)
Differentiation of the SH-SY5Y Human Neuroblastoma Cell Line
Mackenzie M. Shipley et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2016)
Neuroprotective effects of (Val8)GLP-1-Glu-PAL in the MPTP Parkinson's disease mouse model
YanFang Zhang et al.
BEHAVIOURAL BRAIN RESEARCH (2015)
Researching glutamate - induced cytotoxicity in different cell lines: a comparative/collective analysis/study
Aristeidis A. Kritis et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2015)
Incretin mimetics as pharmacologic tools to elucidate and as a new drug strategy to treat traumatic brain injury
Nigel H. Greig et al.
ALZHEIMERS & DEMENTIA (2014)
Characterization of [125I]GLP-1 (9-36), a novel radiolabeled analog of the major metabolite of glucagon-like peptide 1 to a receptor distinct from GLP1-R and function of the peptide in murine aorta
Rhoda E. Kuc et al.
LIFE SCIENCES (2014)
Operational dissection of -amyloid cytopathic effects on cultured neurons
Noelle Callizot et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2013)
Liraglutide, a long-acting GLP-1 mimetic, and its metabolite attenuate inflammation after intracerebral hemorrhage
Jack Hou et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2012)
Allosteric Modulation of the Activity of the Glucagon-like Peptide-1 (GLP-1) Metabolite GLP-1 9-36 Amide at the GLP-1 Receptor
Naichang Li et al.
PLOS ONE (2012)
Functional importance of GLP-1 receptor species and expression levels in cell lines
Lotte Bjerre Knudsen et al.
REGULATORY PEPTIDES (2012)
Allosteric Modulation of Endogenous Metabolites as an Avenue for Drug Discovery
Denise Wootten et al.
MOLECULAR PHARMACOLOGY (2012)
Involvement of the CD200 receptor complex in microglia activation in experimental glaucoma
Sarah Taylor et al.
EXPERIMENTAL EYE RESEARCH (2011)
GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and Parkinsonism
Yazhou Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
GLP-1 agonists facilitate hippocampal LTP and reverse the impairment of LTP induced by beta-amyloid
Victor A. Gault et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
GLP-1 (9-36) amide, cleavage product of GLP-1 (7-36) amide, is a glucoregulatory peptide
Dariush Elahi et al.
OBESITY (2008)
The glucagon-like peptide-1 metabolite GLP-1-(9-36) amide reduces postprandial glycemia independently of gastric emptying and insulin secretion in humans
JJ Meier et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2006)
The incretin approach for diabetes treatment - Modulation of islet hormone release by GLP-1 agonism
JJ Holst et al.
DIABETES (2004)
The major glucagon-like peptide-1 metabolite, GLP-1-(9-36)-amide, does not affect glucose or insulin levels in mice
B Rolin et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2004)
Glucagon-like peptide-1 decreases endogenous amyloid-β peptide (Aβ) levels and protects hippocampal neurons from death induced by Aβ and iron
T Perry et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2003)
Protection and reversal of excitotoxic neuronal damage by glucagon-like peptide-1 and exendin-4
T Perry et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
GLP-1-(9-36) amide reduces blood glucose in anesthetized pigs by a mechanism that does not involve insulin secretion
CF Deacon et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2002)
A novel neutrotrophic property of glucagon-like peptide 1: A promoter of nerve growth factor-mediated differentiation in PC12 cells
T Perry et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Signaling by reactive oxygen species in the nervous system
P Maher et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2000)
分享论文
